Basilea Lands New BARDA Funding for Resistant UTI Antibiotic
ALLSCHWIL, Switzerland — May 28, 2026 Basilea Pharmaceutica announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA),...
Gram-negative infections
Advertisement
smartbax In-Licenses Novel Gram-Negative Antibiotic From Aicuris
MUNICH, Germany, January 20, 2026 — smartbax, a biotechnology company focused on next-generation antibiotics, announced the in-licensing of a...
FDA Fast-Tracks Blacksmith’s FG-2101, a Novel Antibiotic Targeting LpxC
SAN DIEGO, California, October 13, 2025 – In a major advancement for antimicrobial innovation, Blacksmith Medicines, Inc. announced that...
Advertisement
